Response Biomedical expands distribution of cardiovascular products in the U.S.

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute ...

Vancouver's Response Biomedical Corp. (TSC: RBM) (OTCBB: RPBIF) has entered into a distribution agreement with Laboratory Supply Company, Inc. (LABSCO) in Louisville, Kentucky, to distribute cardiovascular products in the U.S. to hospitals with fewer than 150 beds.

LABSCO is the largest privately held distributor of clinical lab products in the U.S.

"This is a very important agreement for Response as it marks a significant step into the U.S. market for POCT [point-of-care testing] in the cardiovascular areana, which is one of the largest markets in the world," said Tim Shannon, Response Biomedical Corp.'s senior vice-president of worldwide sales and marketing.

"LABSCO has the experience and reputation to maximize our efforts to gain traction and to help us penetrate a market that we believe will greatly enhance our growth in the near term and beyond."

The POCT market in the U.S. is worth an estimated $3.1 billion.

ecrawford@biv.com

@EmmaCrawfordBIV

comments powered by Disqus

Also Read

More From Technology

Small Vancouver firm says technology will allow it to offer cellphone plans for $10 a month

Read Article

The University of British Columbia expects a $66.5 million grant from the Canada First Research Excellence Fund to create as many as 44 new jobs. 

Read Article

Vistara Capital Partners, the brainchild of Fabio Banducci and Randy Garg, announced Wednesday (July 29) it’s raised $100 million for the five-month-old growth capital fund.

Read Article

The Match Group set to inherit data from 100 million PlentyOfFish users  

Read Article

Tyler Orton discusses PlentyOfFish's anti-spam fines

Read Article

Subscribe to our mailing lists

* indicates required

Newsletters

* You can modify your newsletter subscriptions at the bottom of any newsletter you receive.
×